EichorEICHOR
Condition: Antiretroviral Agents Synced from ClinicalTrials.gov · August 04, 2026

Recruiting studies: Antiretroviral Agents

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Variation in Drug Interactions in People With HIV (PLWH) Aged 60 Years and Older.
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06717581
SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy
Phase 1/Phase 2 · 1 location(s) · Yale University · NCT05586581
Transitional Housing and HIV Health
Phase N/A · 2 location(s) · University of Pennsylvania · NCT06829394
Observational Study on Patients With HIV/AIDS(OSPWH)
Phase N/A · 1 location(s) · Guangzhou 8th People's Hospital · NCT04667026
HIV Self-testing for Partners of HIV-uninfected Postpartum Women
NA · 1 location(s) · Massachusetts General Hospital · NCT07194902
Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretrovir
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06819176
Kuwa Free! - Live Free!
NA · 1 location(s) · University of Alabama at Birmingham · NCT05044962
Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch
Phase 3 · 3 location(s) · Chelsea and Westminster NHS Foundation Trust · NCT04892654
Prospective Multicenter Study of the Relationship Between Virological Effectiveness and Compliance in HIV-1-infected Pat
Phase N/A · 8 location(s) · Association pour la promotion de la recherche en maladies in · NCT06902142
PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01)
Phase 1 · 1 location(s) · University of California, San Francisco · NCT03729752
Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal o
NA · 5 location(s) · Centre Hospitalier Régional d'Orléans · NCT06834113
Structured Peer-delivered ART and Reentry Community Strategy
NA · 1 location(s) · Johns Hopkins University · NCT06027671
REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE
Phase 4 · 10 location(s) · CAN Community Health · NCT07476339
The MARVIN Chatbots to Provide Information for Different Health Conditions
NA · 2 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT05789901
HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV
NA · 1 location(s) · University of Washington · NCT06126913
Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral
Phase N/A · 2 location(s) · Michael Hoelscher · NCT06267508
Gathering Records to Evaluate Antiretroviral Treatment-South Africa
Phase N/A · 1 location(s) · Boston University · NCT04149782
Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV
Phase 2 · 1 location(s) · Code Pharma · NCT06676410
Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)
Phase 3 · 52 location(s) · Population Health Research Institute · NCT05580666
The DART DELIVER-02 Study
Phase 1 · 3 location(s) · University of North Carolina, Chapel Hill · NCT07217379
HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label
Phase 2 · 1 location(s) · Centre de Recherches et d'Etude sur la Pathologie Tropicale · NCT04513626
Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy
Phase 2 · 1 location(s) · Abdelrahman Mahmoud · NCT07336797
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adult
Phase 3 · 3 location(s) · Gilead Sciences · NCT07682961
Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk Environments
NA · 1 location(s) · San Diego State University · NCT06771843
Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study
Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05652478
Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control
Phase 2 · 17 location(s) · ANRS, Emerging Infectious Diseases · NCT05300035
Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR)
Phase N/A · 11 location(s) · Yaşar Bayındır, MD · NCT07737340
Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir Alafe
Phase 4 · 1 location(s) · Instituto Mexicano del Seguro Social · NCT07678268
Integrated Mental Health Care for Pregnant Women With HIV in Kenya: The Tunawiri Study
NA · 1 location(s) · University of Colorado, Denver · NCT06117163
Post Analytic Treatment Interruption Study
Phase N/A · 1 location(s) · SEARCH Research Foundation · NCT02761200
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →